Tag:
Fampyra
Latest Headlines
Latest Headlines
EU watchdogs reverse course on Fampyra
Reversing an earlier decision, European regulators have recommended approving Acorda Therapeutics' drug Fampyra, which is designed to improve the walking ability of patients with multiple sclerosis.
